151 related articles for article (PubMed ID: 36580152)
1. Conversion ratios for opioid switching: a pragmatic study.
Mercadante S; Adile C; Ferrera P; Grassi Y; Cascio AL; Casuccio A
Support Care Cancer; 2022 Dec; 31(1):91. PubMed ID: 36580152
[TBL] [Abstract][Full Text] [Related]
2. Switching to Intravenous Methadone in Advanced Cancer Patients: A Retrospective Analysis.
Mercadante S; Cascio AL; Casuccio A
J Pain Symptom Manage; 2023 Oct; 66(4):287-292. PubMed ID: 37236430
[TBL] [Abstract][Full Text] [Related]
3. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
Mercadante S
Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
[TBL] [Abstract][Full Text] [Related]
4. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
5. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
6. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
7. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
8. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
9. Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids.
Mercadante S; Porzio G; Aielli F; Adile C; Verna L; Ficorella C; Giarratano A; Casuccio A
Curr Med Res Opin; 2013 Jun; 29(6):661-6. PubMed ID: 23540512
[TBL] [Abstract][Full Text] [Related]
10. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
[TBL] [Abstract][Full Text] [Related]
11. Changes of QTc interval after opioid switching to oral methadone.
Mercadante S; Prestia G; Adile C; Casuccio A
Support Care Cancer; 2013 Dec; 21(12):3421-4. PubMed ID: 23949740
[TBL] [Abstract][Full Text] [Related]
12. Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit.
Mercadante S; Prestia G; Ranieri M; Giarratano A; Casuccio A
Support Care Cancer; 2013 Jul; 21(7):1853-9. PubMed ID: 23400316
[TBL] [Abstract][Full Text] [Related]
13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
[TBL] [Abstract][Full Text] [Related]
15. Maddalena Opioid Switching Score in patients with cancer pain.
Mercadante S; Lo Cascio A; Adile C; Ferrera P; Casuccio A
Pain; 2023 Jan; 164(1):91-97. PubMed ID: 35500284
[TBL] [Abstract][Full Text] [Related]
16. Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.
Santiago-Palma J; Khojainova N; Kornick C; Fischberg DJ; Primavera LH; Payne R; Manfredi P
Cancer; 2001 Oct; 92(7):1919-25. PubMed ID: 11745266
[TBL] [Abstract][Full Text] [Related]
17. Dose ratios between high dose oral morphine or equivalents and oral methadone.
Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
[TBL] [Abstract][Full Text] [Related]
18. Methadone for cancer pain: what have we learned from clinical studies?
Soares LG
Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
20. A better interpretation of data regarding the opioid switching to methadone.
Mercadante S
BMC Palliat Care; 2023 Jun; 22(1):65. PubMed ID: 37280564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]